Immunohistochemistry of the lung cancer tissue sections showed that the expression of CIP2A was frequently observed in the clinical tumor samples from the NSCLC patients and that the expression of CIP2A in the tumor samples was correlated with the expressions of p-AKT and Elk-1 (Figure 6A). This evidence concerns the gene ELK1 and non-small cell lung carcinoma.